Syros Pharmaceuticals Inc (SYRS)
0.3263
-0.03
(-9.34%)
USD |
NASDAQ |
Nov 14, 10:32
Syros Pharmaceuticals Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 28, 2024 | 9.160 |
| June 27, 2024 | 10.17 |
| June 26, 2024 | 10.12 |
| June 25, 2024 | 10.30 |
| June 24, 2024 | 10.31 |
| June 21, 2024 | 9.905 |
| June 20, 2024 | 9.426 |
| June 18, 2024 | 9.479 |
| June 17, 2024 | 10.14 |
| June 14, 2024 | 10.65 |
| June 13, 2024 | 10.30 |
| June 12, 2024 | 9.586 |
| June 11, 2024 | 9.320 |
| June 10, 2024 | 9.089 |
| June 07, 2024 | 9.142 |
| June 06, 2024 | 9.408 |
| June 05, 2024 | 9.408 |
| June 04, 2024 | 9.337 |
| June 03, 2024 | 9.106 |
| May 31, 2024 | 9.053 |
| May 30, 2024 | 8.876 |
| May 29, 2024 | 8.964 |
| May 28, 2024 | 8.876 |
| May 24, 2024 | 8.822 |
| May 23, 2024 | 9.142 |
| Date | Value |
|---|---|
| May 22, 2024 | 9.515 |
| May 21, 2024 | 10.03 |
| May 20, 2024 | 9.958 |
| May 17, 2024 | 9.674 |
| May 16, 2024 | 9.728 |
| May 15, 2024 | 9.781 |
| May 14, 2024 | 9.639 |
| May 13, 2024 | 8.982 |
| May 10, 2024 | 8.822 |
| May 09, 2024 | 8.894 |
| May 08, 2024 | 8.876 |
| May 07, 2024 | 9.142 |
| May 06, 2024 | 9.018 |
| May 03, 2024 | 9.106 |
| May 02, 2024 | 9.231 |
| May 01, 2024 | 9.657 |
| April 30, 2024 | 9.586 |
| April 29, 2024 | 9.550 |
| April 26, 2024 | 8.947 |
| April 25, 2024 | 9.053 |
| April 24, 2024 | 9.00 |
| April 23, 2024 | 9.124 |
| April 22, 2024 | 8.858 |
| April 19, 2024 | 8.059 |
| April 18, 2024 | 8.379 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4291
Minimum
Mar 28 2023
17.91
Maximum
Dec 23 2020
3.894
Average
2.363
Median
Price to Book Value Benchmarks
| Baxter International Inc | 2.148 |
| AbbVie Inc | 49.54 |
| Elanco Animal Health Inc | 1.061 |
| Opus Genetics Inc | 0.6898 |
| Entrada Therapeutics Inc | 1.738 |
Price to Book Value Related Metrics
| PS Ratio | 1.208 |
| Price | 0.3263 |
| Earnings Yield | -940.9% |
| Market Cap | 8.755M |